Zoledronic acid effects on pain in patients with prostate cancer and bone metastases in a randomized placebo-controlled trial

被引：0
|
作者：
Arbuckle, R. [1 ]
Saad, F. [1 ]
机构：
[1] Univ Montreal, Ctr Hosp, Hop Notre Dame, Montreal, PQ, Canada
来源：
CANCER TREATMENT REVIEWS | 2006年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [1] A controlled prospective randomized placebo-controlled trial of Zoledronic acid in bony metastatic bladder cancer patients
    Zaghloul, M. S.
    Boutrus, R.
    El-Hosieny, H.
    A-Kader, Y.
    El-Attar, I.
    Nazmy, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Impact of zoledronic acid (Z) on pain in prostate cancer patients with bone metastases in a randomised placebo-control trial.
    Abetz, L.
    Barghout, V.
    Arbuckle, R.
    Bosch, V.
    Shirina, N.
    Saad, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 251S - 251S
  • [3] A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    Saad, F
    Gleason, DM
    Murray, R
    Tchekmedyian, S
    Venner, P
    Lacombe, L
    Chin, JL
    Vinholes, JJ
    Goas, JA
    Chen, B
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (19) : 1458 - 1468
  • [4] Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: A randomized, placebo-controlled trial
    Kohno, N
    Aogi, K
    Minami, H
    Nakamura, S
    Asaga, T
    Iino, Y
    Watanabe, T
    Goessl, C
    Ohashi, Y
    Takashima, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3314 - 3321
  • [5] Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial
    Minami, Hironobu
    Kohno, Norio
    Aogi, Kenjiro
    Nakamura, Seigo
    Asaga, Taro
    Iino, Yuichi
    Watanabe, Toru
    Goessl, Carsten
    Ohashi, Yasuo
    Takashima, Shigemitsu
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 51 - 52
  • [6] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    Winquist, E
    Berry, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) : 1183 - 1183
  • [7] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    Atkins, CD
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04) : 332 - 332
  • [8] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    Tu, SM
    Lin, SH
    Logothetis, C
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1174 - 1175
  • [9] A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
    Zaghloul, Mohamed S.
    Boutrus, Rimoun
    El-Hossieny, Hisham
    Kader, Yasser Abdel
    El-Attar, Inas
    Nazmy, Mohamed
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 382 - 389
  • [10] A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
    Mohamed S. Zaghloul
    Rimoun Boutrus
    Hisham El-Hossieny
    Yasser Abdel Kader
    Inas El-Attar
    Mohamed Nazmy
    [J]. International Journal of Clinical Oncology, 2010, 15 : 382 - 389
12345